Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Inga

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
BMC Cancer|November 22, 2013
Identification of new p53 target microRNAs by bioinformatics and functional analysisAlessandra Bisio, Veronica De Sanctis, Valerio Del Vescovo, et al.
Journal of Natural Products|April 2, 2013
Α-mangostin and gambogic acid as potential inhibitors of the p53-MDM2 interaction revealed by a yeast approachMariana Leão, Sara Gomes, José Pedraza-Chaverri, et al.
Plos Genetics|August 21, 2008
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53Jennifer J Jordan, Daniel Menendez, Alberto Inga, et al.
Pediatric Blood & Cancer|March 17, 2010
MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastomaStefano Parodi, Chiara Perfumo, Alberto Garaventa, et al.
Biochimie|October 14, 2023
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter siteMatúš Vojsovič, Libuše Kratochvilová, Natália Valková, et al.
Plos One|December 8, 2017
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer developmentWilliam Bruno, Virginia Andreotti, Alessandra Bisio, et al.
Oncogene|August 15, 2003
Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assayPaola Monti, Paola Campomenosi, Yari Ciribilli, et al.
Molecules (Basel, Switzerland)|August 15, 2018
Synthesis of 2,6-Diamino-Substituted Purine Derivatives and Evaluation of Cell Cycle Arrest in Breast and Colorectal Cancer CellsBartolomeo Bosco, Andrea Defant, Andrea Messina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Transcriptional functionality of germ line p53 mutants influences cancer phenotypePaola Monti, Yari Ciribilli, Jennifer Jordan, et al.
Mutation Research|October 31, 2009
Mutagenicity of N3-methyladenine: a multi-translesion polymerase affairPaola Monti, Ilaria Traverso, Laura Casolari, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
BMC Cancer|November 22, 2013
Identification of new p53 target microRNAs by bioinformatics and functional analysisAlessandra Bisio, Veronica De Sanctis, Valerio Del Vescovo, et al.
Journal of Natural Products|April 2, 2013
Α-mangostin and gambogic acid as potential inhibitors of the p53-MDM2 interaction revealed by a yeast approachMariana Leão, Sara Gomes, José Pedraza-Chaverri, et al.
Plos Genetics|August 21, 2008
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53Jennifer J Jordan, Daniel Menendez, Alberto Inga, et al.
Pediatric Blood & Cancer|March 17, 2010
MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastomaStefano Parodi, Chiara Perfumo, Alberto Garaventa, et al.
Biochimie|October 14, 2023
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter siteMatúš Vojsovič, Libuše Kratochvilová, Natália Valková, et al.
Plos One|December 8, 2017
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer developmentWilliam Bruno, Virginia Andreotti, Alessandra Bisio, et al.
Oncogene|August 15, 2003
Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assayPaola Monti, Paola Campomenosi, Yari Ciribilli, et al.
Molecules (Basel, Switzerland)|August 15, 2018
Synthesis of 2,6-Diamino-Substituted Purine Derivatives and Evaluation of Cell Cycle Arrest in Breast and Colorectal Cancer CellsBartolomeo Bosco, Andrea Defant, Andrea Messina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Transcriptional functionality of germ line p53 mutants influences cancer phenotypePaola Monti, Yari Ciribilli, Jennifer Jordan, et al.
Mutation Research|October 31, 2009
Mutagenicity of N3-methyladenine: a multi-translesion polymerase affairPaola Monti, Ilaria Traverso, Laura Casolari, et al.
Pageof 11